Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. med. biol. res ; 48(2): 161-166, 02/2015. tab, graf
Artigo em Inglês | LILACS | ID: lil-735848

RESUMO

Our aim was to investigate the role of chemokines in promoting instability of coronary atherosclerotic plaques and the underlying molecular mechanism. Coronary angiography and intravascular ultrasound (IVUS) were performed in 60 stable angina pectoris (SAP) patients and 60 unstable angina pectoris (UAP) patients. The chemotactic activity of monocytes in the 2 groups of patients was examined in Transwell chambers. High-sensitivity C-reactive protein (hs-CRP), monocyte chemoattractant protein-1 (MCP-1), regulated on activation in normal T-cell expressed and secreted (RANTES), and fractalkine in serum were examined with ELISA kits, and expression of MCP-1, RANTES, and fractalkine mRNA was examined with real-time PCR. In the SAP group, 92 plaques were detected with IVUS. In the UAP group, 96 plaques were detected with IVUS. The plaques in the UAP group were mainly lipid 51.04% (49/96) and the plaques in the SAP group were mainly fibrous 52.17% (48/92). Compared with the SAP group, the plaque burden and vascular remodeling index in the UAP group were significantly greater than in the SAP group (P<0.01). Chemotactic activity and the number of mobile monocytes in the UAP group were significantly greater than in the SAP group (P<0.01). Concentrations of hs-CRP, MCP-1, RANTES, and fractalkine in the serum of the UAP group were significantly higher than in the serum of the SAP group (P<0.05 or P<0.01), and expression of MCP-1, RANTES, and fractalkine mRNA was significantly higher than in the SAP group (P<0.05). MCP-1, RANTES, and fractalkine probably promote instability of coronary atherosclerotic plaque.


Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Angina Pectoris/metabolismo , Quimiocinas/metabolismo , Quimiotaxia/fisiologia , Doença da Artéria Coronariana/metabolismo , Monócitos/metabolismo , Placa Aterosclerótica/fisiopatologia , Angina Pectoris/fisiopatologia , Proteína C-Reativa/análise , /sangue , /sangue , /sangue , Doença da Artéria Coronariana/fisiopatologia , Reação em Cadeia da Polimerase em Tempo Real , Ultrassonografia de Intervenção
2.
RBCF, Rev. bras. ciênc. farm. (Impr.) ; 36(2): 241-7, jul.-dez. 2000. tab, graf
Artigo em Inglês | LILACS | ID: lil-289829

RESUMO

An improved, simple and sensitive micromethod based on HPLC-fluorescence is described for quantification of propranolol in plasma. Only 200µL of biological sample were required. The drug and its internal standard (verapamil) are eluted after 3.6 and 8.5 min, respectively, from a 4-micron `C IND. 18ï reverse-phase column using a mobile phase consisting of 0.38 M acetate buffer, pH 5.0 and acetonitrile (65:35, v/v, isocratically) with detection at `lâmbda IND. exï- 290 nm and `lâmbda IND. emï - 358 nm. This method, validated on basis of parameters evaluated for the confidence limits of propranolol measurements in spiked blank plasma, presented 1 ng/mL sensitivity, 1-1000 ng/mL linearity, 6.2 per cent and 7.6 per cent for intra- and inter-assay precision respectively, good accuracy and high selectivity...


Assuntos
Humanos , Angina Pectoris/metabolismo , Arritmias Cardíacas/metabolismo , Circulação Extracorpórea , Hipertensão/metabolismo , Propranolol/farmacocinética , Cirurgia Torácica , Cromatografia Líquida de Alta Pressão/métodos , Fluorescência , Período Pós-Operatório
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA